Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
Best Practices For Successful Filter Integrity Testing Using Water Intrusion Test (WIT) Method
Monica Cardona and Ian Johnson Pall Life Sciences
Cleanability and Re-Usability of Cadence™ Inline Diafiltration Modules
Navigating Technology Transfer
View All Featured ArticlesHeadline News
FDA places Bright Minds’ planned BMB-101 Phase II epilepsy study on partial clinical hold
Shockwave Javelin IVL catheter shows positive results in pivotal FORWARD CAD study
Impella registry analyses report lower mortality than CHIP-BCIS3 in high-risk PCI
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
Presented by Jeff Doyle & Dr Paul Jeffers, Pfizer. Followed by Jonas Elfving, MKS
07th February 2017
End User Perspective on Setting in-Process Endotoxin Limits
Presented by Dr Friedrich von Wintzingerode, Roche/Genentech
15th May 2018
Case Study: An End-to-End Solution for Large Scale Adenovirus Manufacturing
Presented by Clive Glover, PhD, Senior Marketing Manager, Cell & Gene Therapy at Pall and Rachel Legmann, PhD, Senior Manager, Process Development Services at Pall
13th November 2018
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Rationale Design of Valves for Flexible Processing
Strategy Emerging Markets for Risk Mitigation
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
